Thermo Fisher, NanoPin partner on infectious disease workflows

By staff writers

February 14, 2020 -- Thermo Fisher Scientific is partnering with infectious disease diagnostic company NanoPin Technologies to develop workflows for liquid chromatography-mass spectrometry (LC-MS).

The partnership will utilize Thermo Fisher's LC-MS technology and NanoPin's diagnostic platform to identify disease-related antigens from patient blood samples, Thermo Fisher said.

The goal is for the companies' combined technologies to lead to the development of sensitive clinical assays for infectious diseases, ultimately reducing time to results.

Copyright © 2020

To read this and get access to all of the exclusive content on, create a free account or sign in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?